Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
克立硼罗治疗 3 至 < 24 个月龄轻度至中度特应性皮炎婴儿的安全性、有效性和药代动力学:一项 IV 期开放标签研究 (CrisADe CARE 1)
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-020-00510-6
Schlessinger, Joel; Shepard, Julie S; Gower, Richard; Su, John C; Lynde, Charles; Cha, Amy; Ports, William C; Purohit, Vivek; Takiya, Liza; Werth, John L; Zang, Chuanbo; Vlahos, Bonnie